Patents by Inventor Eric H. Baehrecke

Eric H. Baehrecke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Function of autophagy genes in cell death
    Patent number: 7838645
    Abstract: The present invention relates to a new molecular pathway in which activation of the receptor-interacting protein (RIP, a serine-threonine kinase) and Jun N-terminal kinase induce cell death with the morphology of autophagy. Further, autophagic death is induced by caspase 8 inhibition and expression of the mammalian genes ATG7 and beclin.
    Type: Grant
    Filed: May 2, 2005
    Date of Patent: November 23, 2010
    Assignees: University of Maryland College Park, National Institutes of Health
    Inventors: Eric H. Baehrecke, Ajjai Alva, Michael J. Lenardo, Yu Li
  • Genes regulating programmed cell death
    Patent number: 7033767
    Abstract: The present invention to amino acid sequences of proteins that are associated with apoptosis and the use of these proteins in the diagnosis, prevention and treatment of disorders associated with abnormal cell proliferation and apoptosis. The invention relates as well to nucleotide sequences encoding the peptides, recombinant vectors carrying the sequences, recombinant host cells including either the sequences or vectors, and recombinant peptides. The invention further includes methods for using the nucleotide sequences and recombinant peptides in diagnostic and therapeutic applications.
    Type: Grant
    Filed: October 29, 2001
    Date of Patent: April 25, 2006
    Assignee: University of Maryland Biotechnology Institute
    Inventor: Eric H. Baehrecke
  • Genes regulating programmed cell death
    Publication number: 20020142443
    Abstract: The present invention to amino acid sequences of proteins that are associated with apoptosis and the use of these proteins in the diagnosis, prevention and treatment of disorders associated with abnormal cell proliferation and apoptosis. The invention relates as well to nucleotide sequences encoding the peptides, recombinant vectors carrying the sequences, recombinant host cells including either the sequences or vectors, and recombinant peptides. The invention further includes methods for using the nucleotide sequences and recombinant peptides in diagnostic and therapeutic applications.
    Type: Application
    Filed: October 29, 2001
    Publication date: October 3, 2002
    Inventor: Eric H. Baehrecke